BioCentury
ARTICLE | Politics & Policy

GSK to release all clinical trial reports

February 6, 2013 1:52 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) became the first pharma to publicly support the AllTrials campaign, which is calling for the disclosure of clinical trial results and clinical study reports to increase trial transparency. GSK, which in October committed to release anonymized patient-level data, said in a statement on Tuesday that it will also now make publicly available clinical trial reports -- which are formal reports that provide details on the design, methods and results of trials and may also form the basis of regulatory applications -- for all of its drugs once they have been approved or discontinued from development and the results have been published. GSK said it also plans to make reports available for clinical outcomes trials for all of its already approved drugs dating back to the company's formation, with priority to its most commonly prescribed drugs (see BioCentury Extra, Oct. 11, 2012). ...